Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Patients with metastatic progression on or shortly after durvalumab consolidation for stage III NSCLC should be treated

As patients who progressed on both chemotherapy and immunotherapy for advanced disease

Date

20 Sep 2021

Session

Patients with metastatic progression on or shortly after durvalumab consolidation for stage III NSCLC should be treated

Presenters

Suresh Ramalingam

Authors

S.S. Ramalingam

Author affiliations

  • Hematology And Medical Oncology Department, Winship Cancer Institute of Emory University, 30322 - Atlanta/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction by the chair

Presenter: Edward Garon

Session: Patients with metastatic progression on or shortly after durvalumab consolidation for stage III NSCLC should be treated

Resources:

Slides

Webcast

Polling 2 (led by chair)

Presenter: Edward Garon

Session: Patients with metastatic progression on or shortly after durvalumab consolidation for stage III NSCLC should be treated

Resources:

Slides

Webcast

Q&A

Presenter: Edward Garon

Session: Patients with metastatic progression on or shortly after durvalumab consolidation for stage III NSCLC should be treated

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.